Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112724180A reveals a high-yield chemical route for beta-nicotinamide mononucleotide, offering cost reduction and scalable manufacturing for global supply chains.
Patent CN102351713B details green degradation for high purity 2,6-difluoroaniline. Ensures supply chain stability and cost reduction for global buyers.
Novel condensation method for Tandutinib reduces hazardous reagents. Enhances supply chain reliability and cost efficiency for pharmaceutical manufacturing partners.
Advanced preparation of benzothiophene carboxylic acid amide derivatives via TEMPO oxidation. Offers significant cost reduction in API manufacturing and high stereoselectivity.
Patent CN113788765B reveals a ligand-free carbonylation method reducing costs and enhancing supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Novel one-step method using benzamide and tert-butyl isocyanide offers high yields and simplified purification for reliable guanidine compound supply chains.
Novel synthetic method for Lacosamide intermediate ensuring 99.95% purity. Cost-effective and scalable solution for pharmaceutical manufacturing supply chains.
Patent CN114591198A reveals a green zinc-catalyzed method for cyanoalkynes, offering cost reduction in pharmaceutical manufacturing and safer supply chains.
Patent CN112920114B reveals a novel 3-step catalytic synthesis for hydroxychloroquine sulfate, eliminating toxic phenol solvents and high-pressure risks for cost-effective manufacturing.
Novel B(C6F5)3 catalyzed dehydration route offers >99% purity and reduced waste for reliable pharmaceutical intermediate supply chains.
Novel preparation method for pharmaceutical intermediates ensuring high purity and scalable production for global supply chains and cost efficiency.
Patent CN120329223A reveals a green one-pot synthesis for Tembotrione. This report analyzes cost reduction in herbicide manufacturing and supply chain reliability for global buyers.
Patent CN112979645B reveals a novel Lewis acid-catalyzed route for indolizine derivatives, offering significant cost reduction and green chemistry benefits for API manufacturing.
Patent CN109111386A reveals a high-yield L-prolineamide synthesis. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel activation-condensation route for Sitagliptin intermediates. High yield, industrial scalability, cost-effective alternative to HOBt/EDC methods.
Patent CN101654416A details a scalable synthesis for anticancer intermediates, offering improved yields and safer processing compared to traditional nitro-reduction methods.
Patent CN113461648A discloses a streamlined 2-step synthesis for coumarin-based neuraminidase inhibitors, offering a cost-effective alternative to complex antiviral routes.
Novel 7-step synthesis for Acotiamide derivative ensures high yield and purity. Ideal for functional dyspepsia drug development. Reliable supply chain partner.
Novel solid-liquid strategy for Galaxamide. 99% purity, 84.2% yield. Cost-effective scale-up for pharma intermediates.
Advanced synthesis of Nicotinamide Riboside via mild deacetylation. Patent CN112028954B offers high purity, scalable NAD+ precursor manufacturing with reduced safety risks.